Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO)

被引：4
|
作者：
Iwata, H
Kami, M
Kishi, Y
Oki, Y
Tanaka, Y
Takeuchi, K
Yamazaki, I
Suzuki, R
Morinaga, S
Mutou, Y
机构：
[1] Toranomon Hosp, Dept Hematol, Minato Ku, Tokyo 1058470, Japan
[2] Tokyo Univ Hosp, Dept Hematol & Oncol, Tokyo, Japan
[3] Tokyo Univ Hosp, Dept Pathol, Tokyo, Japan
[4] Inoue Mem Hosp, Dept Clin Lab & Pathol, Chiba, Japan
[5] Aichi Canc Ctr, Lab Chemotherapy, Aichi, Japan
来源：
LEUKEMIA | 2000年 / 14卷 / 11期
关键词：
D O I：
10.1038/sj.leu.2401927
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2013 / 2014
页数：2
相关论文
共 50 条
  • [41] MINIMALLY DIFFERENTIATED ACUTE-LEUKEMIA
    CADWELL, FJ
    BURNS, CP
    DICK, FR
    JONES, MP
    HECKMAN, KD
    WEINER, GJ
    GOEKEN, JA
    LEUKEMIA RESEARCH, 1993, 17 (03) : 199 - 208
  • [42] Features and Outcome of Patients (Pts) with New Diagnosis of Acute Myeloid Leukemia (AML) with Monocytic Differentiation (AML-Mo) Following Standard Induction Therapy. Do We Need a Different Strategy?
    McCloskey, James K.
    Depadova, Samantha
    Koprivnikar, Jamie L.
    Andrews, Tracy
    McKenna, Marshall
    Stanislaus, Genique
    Goldberg, Stuart L.
    Faderl, Stefan
    BLOOD, 2016, 128 (22)
  • [43] AngioCRIME in Acute Myeloid Leukemia (AML)
    Macintyre, Elizabeth
    HEMASPHERE, 2017, 1 (01):
  • [44] MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA - A MORPHOLOGIC, CYTOCHEMICAL AND ULTRASTRUCTURAL-STUDY
    ALURKAR, SS
    CHOPRA, HK
    NAIR, CN
    ZACHARIAH, LV
    BADRINATH, Y
    CHOUGULE, A
    DHOND, S
    KUMAR, KA
    BARBHAYH, SA
    ADVANI, SH
    TUMORI, 1992, 78 (03) : 185 - 189
  • [45] CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia
    Tien, HF
    Wang, CH
    LEUKEMIA & LYMPHOMA, 1998, 31 (1-2) : 93 - 98
  • [46] Diagnostic and Prognostic Value of CD123 in Acute Myeloid Leukemia (AML)
    Eldin, Taghreed Kamal
    Abdelsalam, Eman M. Nagiub
    Razek, Ghadeer Abdel
    Nafady, Howaida
    Saleh, Mostafa F. Mohammed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S272 - S273
  • [47] Immunophenotypic and cytogenetic features in patients with minimally differentiated acute myeloid leukaemia (AML-M0)
    Saso, R
    Kulkarni, S
    Killick, S
    Rege, K
    Mehta, J
    Swansbury, J
    Matutes, E
    Atra, A
    Morilla, R
    Powles, R
    Treleaven, J
    Catovsky, D
    BONE MARROW TRANSPLANTATION, 1998, 21 : S8 - S8
  • [48] Minimally differentiated acute myeloid leukemia (AML-M0) with extensive erythrophagocytosis and del(20)(q11) chromosome abnormality
    Mori, H
    Tawara, M
    Yoshida, Y
    Kuriyama, K
    Sugahara, K
    Kamihira, S
    Tomonaga, M
    LEUKEMIA RESEARCH, 2000, 24 (01) : 87 - 90
  • [49] Decision criteria for the futility of intensive chemotherapy in older patients with acute myeloid leukemia (AML)
    Dombrel, Herve
    Malfuson, Jean-Valere
    Etienne, Anne
    Turlure, Pascal
    de Revel, Thierry
    Thomas, Xavier
    Contentin, Nathalie
    Terre, Christine
    Michallet, Mauricette
    Castaigne, Sylvie
    Bordessoule, Dominique
    Vey, Norbert
    Gardin, Claude
    BLOOD, 2007, 110 (11) : 841A - 842A
  • [50] NCI Common Toxicity Criteria and Mortality After Chemotherapy for Acute Myeloid Leukemia (AML)
    Veatch, Joshua R.
    Sandhu, Ravinder K.
    Shannon-Dorcy, Kathleen
    Pagel, John M.
    Becker, Pamela S.
    Petersdorf, Stephen
    Appelbaum, Frederick R.
    Estey, Elihu H.
    BLOOD, 2012, 120 (21)
12345